Insights

Why Novavax Stock Jumped Today

What happened

Shares of the coronavirus vaccine developer Novavax (NASDAQ: NVAX) were up by more than 10.3% as of 11:01 a.m. ET today thanks to a well-received series of six presentations that the company’s scientists gave at the Communicable Diseases and Immunisation Conference 2022 in Sydney, Australia.

The company’s talks and participation at the conference, which started June 20 and concludes today, are about topics like addressing vaccine hesitancy, safely co-administering combination coronavirus and influenza vaccines, and the efficacy of vaccine efficacy-boosting compounds called adjuvants, all presented within the context of Novavax’s clinical data. 

So what

Novavax explicitly states that the safety and efficacy data it’s referencing in its presentations are not new to the public, so the market is not reacting to new information that might directly affect the revenue it can get from sales of its coronavirus jab. 

Nonetheless, biotech stocks often get a bump in their share prices when companies reiterate a few of their most important results and accomplishments at conferences. So it’s likely that investors were paying close attention to what Novavax presented.

Now what

Novavax is still waiting on the Food and Drug Administration to weigh in on whether its coronavirus vaccine Nuvaxovid can be commercialized in the U.S. Though it got a nearly unanimous green light from the non-binding advisory committee on June 7, the upcoming binding committee vote is more important, and it’s also higher risk.

An approval from the binding committee would send Novavax’s shares skyrocketing, but a rejection would be yet another speed bump for the company’s path to selling its jab in the U.S. Either way, its vaccine is approved in a plethora of countries, so investors can expect it to continue to report rising revenue for the near term.

Alex Carchidi has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

  • This field is for validation purposes and should be left unchanged.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;

To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.

An active and funded account with a positive trading balance is required to continue to have access to the tools;

Although the tools are available to you, Monex Securities may at it’s discretion disable access to the tools in the future;

Monex Securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

FREE AAPL, TSLA, AMZN, PFE or MRO Share(s)
REGISTER TO BE ELIGIBLE FOR FREE SHARES
TRAVEL ACROSS THE FINANCIAL WORLD
Act Fast - Promotion Ends In
Click Here To Get Started
FREE AAPL, TSLA, AMZN, PFE or MRO Share(s)
REGISTER TO BE ELIGIBLE FOR FREE SHARES
TRAVEL ACROSS THE FINANCIAL WORLD
Act Fast - Promotion Ends In
Click Here For More Info